Hims & Hers Health (HIMS) is quickly becoming one of the most compelling stories in the market as an emerging powerhouse in the direct-to-consumer healthcare space. The stock has posted outsized gains ...

The Q2 earnings season gets going in earnest this week, with almost 100 companies on deck to report results, including 38 S&P ...

The latest trading day saw IonQ, Inc. (IONQ) settling at $41.81, representing a -8.97% change from its previous close.

The financial sector will take center stage next Tuesday, July 15, with Q2 results from most of the major domestic banks set ...

MSFT, BABA, and MRK lead today's top analyst picks, with AI, e-commerce, and cancer drug strategies in sharp focus.